🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Parkinson › New York

Qorannoo klinikaalii Dhibee Parkinson New York keessatti

Qorannoo 31 Dhibee Parkinson f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  • Northwell Health, Manhasset
  • Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
  • Columbia University, New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06680830

Visual Hallucinations in Lewy Body Diseases

  • NYU Langone Health, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07849413

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  • Site-006, Albany
  • Site-005, New York
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06976268

GBPDC: Gut-Brain in PD Consortium Master Protocol

  • Columbia University, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 21 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07567794

Speech Learning and Speech Production in Parkinson's Disease

  • State University of New York at Buffalo, Buffalo
Namoota walitti qabaa jira
Umuriin 45 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07403539

A Study of Buntanetap in Participants With PD

  • Mount Sinai Hospital, New York
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07284784

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

  • Weill Cornell Medical College, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07005180

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  • Northwell Health Neuroscience Institute, Great Neck
  • University at Buffalo, Williamsville
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT02071134

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #055, Amherst
  • Vima Site #024, New York
  • Vima Site #052, Patchogue
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07804615

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

  • Joan and Sanford I. Weill Department of Medicine (Site #224), New York
  • Mount Sinai School of Medicine (Site #209), New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 30 hanga 80 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07432958

Parkinson's Foundation PD GENEration Genetic Registry

  • Mount Sinai, New York
  • Columbia University, New York
  • University of Rochester Medical Center, Rochester
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT04994015

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  • Northwell Health, New York
  • Stony Brook University, Stony Brook
  • University of Buffalo Jacobs School of Medicine, Williamsville
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07330258

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

  • Albany Medical Center, Albany
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT03664609

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  • Dent Neurological Institute, Amherst
  • Parkinson's Research Centers of America - Long Island, Commack
  • Weill Cornell Medical College, New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07174310

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

  • University of Rochester Center for Health and Technology (CHeT), Rochester
Namoota walitti qabaa jira
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT06993142

Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms

  • NYU Langone Health, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07752355

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  • UBMD Neurology, Buffalo
  • Mount Sinai West - Neurology, New York
  • New York Presbyterian/Weill Cornell Medical Center, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06944522

Autoimmune Features of Neurodegenerative Disorders

  • Columbia University Medical Center, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT04239079

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

  • Radial Midtown Manhattan, New York
Namoota walitti qabaa jira
Umuriin 22 hanga 80 · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT07207122

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  • Beth Israel Medical Center, New York
  • NYU Langone Health, New York
  • University of Rochester, Rochester
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 30 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT04477785

Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects

  • New York Institute of Technology - College of Ostopathic Medicine - Academic Health Care Center - Osteopathic Medicine Center, Old Westbury
Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06671600

Natural History Study of Synucleinopathies

  • NYU Medical Center, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT01799915

Parkinson's Disease Biomarkers in Nerve Cells in the Gut

  • Weill Cornell Medicine, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05347407

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

  • Cornell University Weill Medical College, New York
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 30 hanga 75 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT07102342

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

  • Weill Cornell Medicine, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 30 hanga 99 · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT05539196

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

  • New York Presbyterian Hospital-Columbia University Medical Center, New York
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 40 hanga 72 · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06753331

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

  • Albany Medical Center, Albany
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 08-Ama-2026 · NCT04071847

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

  • Parkinson's Disease and Movement Disorders Center - Long Island, Commack
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Onk-2025 · NCT07219927

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

  • Parkinson's Research Centers of America - Long Island, Commack
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2025 · NCT06765668

NYSCF Scientific Discovery Biobank

  • New York Stem Cell Foundation Research Institute, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
30 Days · Saalaa hunda · Haaromfame 03-Bit-2025 · NCT06203106

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

  • Teachers College, Columbia University, New York
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 50 hanga 80 · Saalaa hunda · Haaromfame 15-Hag-2024 · NCT06540989

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.